Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Borghgraef

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|October 29, 2004
beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic miceMichael Willem, Ilse Dewachter, Neil Smyth, et al.
Biochimica Et Biophysica Acta|March 25, 2010
Alzheimer's disease: old problem, new views from transgenic and viral modelsTomasz Jaworski, Ilse Dewachter, Claire Marie Seymour, et al.
Oncotarget|June 4, 2016
Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer's diseaseSylvie L Lesuis, Herve Maurin, Peter Borghgraef, et al.
Neurobiology of Disease|April 8, 2014
Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathyNatalia Crespo-Biel, Clara Theunis, Peter Borghgraef, et al.
NMR in Biomedicine|November 30, 2018
Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathologyKristof Govaerts, Benoit Lechat, Tom Struys, et al.
The American Journal of Pathology|January 19, 2008
Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degenerationDavid Muyllaert, Dick Terwel, Anna Kremer, et al.
Plos One|October 25, 2011
Age-related impairment of ultrasonic vocalization in Tau.P301L mice: possible implication for progressive language disordersClément Menuet, Yves Cazals, Christian Gestreau, et al.
Biochemistry|August 24, 2005
Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeastTom Vandebroek, Thomas Vanhelmont, Dick Terwel, et al.
Biochimica Et Biophysica Acta|December 14, 2004
Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice modelsAlain Boom, Roland Pochet, Michele Authelet, et al.
Neurobiology of Disease|February 10, 2012
Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseasesClément Menuet, Peter Borghgraef, Nicolas Voituron, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|October 29, 2004
beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic miceMichael Willem, Ilse Dewachter, Neil Smyth, et al.
Biochimica Et Biophysica Acta|March 25, 2010
Alzheimer's disease: old problem, new views from transgenic and viral modelsTomasz Jaworski, Ilse Dewachter, Claire Marie Seymour, et al.
Oncotarget|June 4, 2016
Positive and negative early life experiences differentially modulate long term survival and amyloid protein levels in a mouse model of Alzheimer's diseaseSylvie L Lesuis, Herve Maurin, Peter Borghgraef, et al.
Neurobiology of Disease|April 8, 2014
Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathyNatalia Crespo-Biel, Clara Theunis, Peter Borghgraef, et al.
NMR in Biomedicine|November 30, 2018
Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathologyKristof Govaerts, Benoit Lechat, Tom Struys, et al.
The American Journal of Pathology|January 19, 2008
Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degenerationDavid Muyllaert, Dick Terwel, Anna Kremer, et al.
Plos One|October 25, 2011
Age-related impairment of ultrasonic vocalization in Tau.P301L mice: possible implication for progressive language disordersClément Menuet, Yves Cazals, Christian Gestreau, et al.
Biochemistry|August 24, 2005
Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeastTom Vandebroek, Thomas Vanhelmont, Dick Terwel, et al.
Biochimica Et Biophysica Acta|December 14, 2004
Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice modelsAlain Boom, Roland Pochet, Michele Authelet, et al.
Neurobiology of Disease|February 10, 2012
Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseasesClément Menuet, Peter Borghgraef, Nicolas Voituron, et al.
Pageof 5